Roland Fenk
About
Roland Fenk is a scholar working on Hematology, Oncology and Molecular Biology.
According to data from OpenAlex, Roland Fenk has authored 110 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Hematology, 37 papers in Oncology and 31 papers in Molecular Biology. Recurrent topics in Roland Fenk's work include Multiple Myeloma Research and Treatments (50 papers), Hematopoietic Stem Cell Transplantation (35 papers) and Acute Myeloid Leukemia Research (29 papers). Roland Fenk is often cited by papers focused on Multiple Myeloma Research and Treatments (50 papers), Hematopoietic Stem Cell Transplantation (35 papers) and Acute Myeloid Leukemia Research (29 papers). Roland Fenk collaborates with scholars based in Germany, United States and Switzerland. Roland Fenk's co-authors include Rainer Haas, Guido Kobbe, Ingmar Bruns, Ralf Kronenwett, Akos Czibere, Thomas Schroeder, Fabian Zohren, Ulrich Germing, Frank Neumann and Ulrich‐Peter Rohr and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
In The Last Decade
Roland Fenk
107 papers receiving 2.5k citations
Peers
Roland Fenk
Patrick Wuchter Germany
Mehrdad Abedi United States
Saurabh Chhabra United States
Joy Y. Wu United States
Timothy Campbell United States
Joerg Faber Germany
Rakash Nayar Canada
MJ Fackler United States
Noemí Puig Spain
Vinod K. Prasad United States
Citations per year, relative to Roland Fenk Roland Fenk (= 1×)
peers
Patrick Wuchter
Countries citing papers authored by Roland Fenk
Since
Specialization
Citations
This map shows the geographic impact of Roland Fenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Fenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Fenk more than expected).
Fields of papers citing papers by Roland Fenk
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Roland Fenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Fenk. The network helps show where Roland Fenk may publish in the future.
Co-authorship network of co-authors of Roland Fenk
This figure shows the co-authorship network connecting the top 25 collaborators of Roland Fenk. A scholar is included among the top collaborators of Roland Fenk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Fenk. Roland Fenk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Koch, Annemarie, Roland Fenk, Uwe Maus, et al.. (2024). Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma. Blood Advances. 8(10). 2575–2588.
2.
Metselaar, Josbert M., Twan Lammers, Roland Fenk, et al.. (2023). A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma. Drug Delivery and Translational Research. 13(4). 915–923.
3.
Hildebrandt, Barbara, Guido Kobbe, Norbert Gattermann, et al.. (2022). Therapy-related myeloid neoplasms following treatment for multiple myeloma—a single center analysis. Annals of Hematology. 101(5). 1031–1038.
4.
Dupré, Mathieu, Magalie Duchateau, Christian Malosse, et al.. (2021). De Novo Sequencing of Antibody Light Chain Proteoforms from Patients with Multiple Myeloma. Analytical Chemistry. 93(30). 10627–10634.
5.
Fenk, Roland, Aristoteles Giagounidis, Hartmut Goldschmidt, et al.. (2020). Efficacy and Tolerability of High- versus Low-dose Lenalidomide Maintenance Therapy of Multiple Myeloma after Autologous Blood Stem Cell Transplantation. Clinical Cancer Research. 26(22). 5879–5886.
6.
Neukirchen, Judith, Ariane Dienst, Kathrin Nachtkamp, et al.. (2016). Favourable Outcome of Elderly Patients with Multiple Myeloma Treated with Tandem Melphalan 100 High-Dose Therapy, Autologous Stem Cell Transplantation and Novel Agents - a Single Center Experience. Blood. 128(22). 3460–3460.
7.
Matuschek, Christiane, Edwin Bölke, Ute Ganswindt, et al.. (2015). Effects of Radiotherapy in the treatment of multiple myeloma: a retrospective analysis of a Single Institution. Radiation Oncology. 10(1). 71–71.
8.
Schroeder, Thomas, Fabian Zohren, Ingmar Bruns, et al.. (2011). Upfront Allogeneic Blood Stem Cell Transplantation for Patients with High-Risk Myelodysplastic Syndrome or Secondary Acute Myeloid Leukemia Using a FLAMSA-Based High-Dose Sequential Conditioning Regimen. Biology of Blood and Marrow Transplantation. 18(3). 466–472.
9.
Schroeder, Thomas, Fabian Zohren, Ingmar Bruns, et al.. (2010). Sorafenib Treatment in 13 Patients with Acute Myeloid Leukemia and Activating FLT3 Mutations in Combination with Chemotherapy or as Monotherapy. Acta Haematologica. 124(3). 153–159.
10.
Kobbe, Guido, Ingmar Bruns, Thomas Schroeder, et al.. (2010). A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma. Annals of Oncology. 21(9). 1898–1904.
11.
Czibere, Akos, Ingmar Bruns, Nicolaus Kröger, et al.. (2009). 5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis. Bone Marrow Transplantation. 45(5). 872–876.
12.
Zohren, Fabian, Akos Czibere, Ingmar Bruns, et al.. (2009). Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia. Bone Marrow Transplantation. 44(12). 785–792.
13.
Neumann, Frank, Roland Fenk, Michael Wulfert, et al.. (2008). Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf study. Hematological Oncology. 26(4). 213–218.
14.
Jacobs, Bénédikt, Claudia Papewalis, Roland Fenk, et al.. (2008). Characterization of Monocyte-derived IFNα-generated Dendritic Cells. Hormone and Metabolic Research. 40(2). 117–121.
15.
Bruns, Ingmar, Ulrich Steidl, Johannes Fischer, et al.. (2008). Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor. Haematologica. 93(3). 347–355.
16.
Fenk, Roland, Ulrich Steidl, Ingmar Bruns, et al.. (2006). Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma. Experimental Hematology. 34(10). 1296–1302.
17.
Strupp, Corinna, Ulrich Germing, Manuel Aivado, et al.. (2005). The ratio between CD4 + and CD8 + cells in the peripheral blood of patients with hematological malignancies is not altered by thalidomide. Leukemia & lymphoma. 46(7). 999–1006.
18.
Steidl, Ulrich, Roland Fenk, Ingmar Bruns, et al.. (2004). Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma. Bone Marrow Transplantation. 35(1). 33–36.
19.
Heyd, Florian, Ulrich Steidl, Roland Fenk, et al.. (2003). Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector. Cancer Gene Therapy. 10(12). 898–906.
20.
Padberg, Frank, Masayuki Matsuda, Roland Fenk, et al.. (1999). Myasthenia gravis: selective enrichment of antiacetylcholine receptor antibody production in untransformed human B cell cultures. European Journal of Immunology. 29(11). 3538–3548.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Patrick Wuchter Breakdown of academic impact, for papers by Mehrdad Abedi Breakdown of academic impact, for papers by Saurabh Chhabra Breakdown of academic impact, for papers by Joy Y. Wu Breakdown of academic impact, for papers by Timothy Campbell Breakdown of academic impact, for papers by Joerg Faber Breakdown of academic impact, for papers by Rakash Nayar Breakdown of academic impact, for papers by MJ Fackler Breakdown of academic impact, for papers by Noemí Puig Breakdown of academic impact, for papers by Vinod K. Prasad